參附注射液在第二產(chǎn)程中應(yīng)用的臨床研究

鄭贛紅+趙令睿+吳云根+杜永艷+鄭程靜子+李紅梅

[摘要] 目的 探討參附注射液在第二產(chǎn)程中的應(yīng)用效果。方法 選擇2017年1～5月在德興市中醫(yī)院住院分娩的80例初產(chǎn)婦作為研究對(duì)象，采用隨機(jī)數(shù)字表法分為觀察組、對(duì)照組，每組40例。觀察組于第二產(chǎn)程開(kāi)始給予5%葡萄糖500 ml+參附注射液40 ml靜脈點(diǎn)滴，對(duì)照組于第二產(chǎn)程開(kāi)始給予5%的葡萄糖500 ml靜脈點(diǎn)滴。比較兩組的第二產(chǎn)程時(shí)間、新生兒1 min Apgar評(píng)分及產(chǎn)后出血量。結(jié)果 觀察組的第二產(chǎn)程時(shí)間短于對(duì)照組，新生兒1 min Apgar評(píng)分高于對(duì)照組，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；觀察組產(chǎn)婦產(chǎn)時(shí)、產(chǎn)后出血量均明顯少于對(duì)照組，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 參附注射液能縮短第二產(chǎn)程，減少產(chǎn)后出血，提高新生兒評(píng)分，為中醫(yī)中藥更廣泛的臨床應(yīng)用提供依據(jù)，為臨床治療提供新方法。

[關(guān)鍵詞]參附注射液；第二產(chǎn)程；應(yīng)用效果；Apgar評(píng)分；出血量

[中圖分類號(hào)] R289.3 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-4721（2017）09（c）-0079-03

[Abstract]Objective To investigate the application effect of Shenfu Injection in the second stage of labor.Methods 80 primiparae with hospital delivery in Traditional Chinese Medicine Hospital of Dexing City from January to May 2017 were selected as the research object，and they were divided into observation group and control group according to random number table method，and there were 40 cases in each group.Observation group was given 5% Glucose 500 ml plusing intravenous drip of Shenfu Injection 40 ml in the second stage of labor，while control group was given intravenous drip of 5% Glucose 500 ml in the second stage of labor.The time of second stage of labor，Apgar 1 min score and postpartum bleeding volume were compared between the two groups.Results The time of second stage of labor in observation group was shorter than that in control group，and Apgar 1 min score was higher than that in control group （P<0.05）.The intrapartum and postpartum bleeding volume of observation group were significantly fewer than those of control group （P<0.05）.Conclusion Shenfu Injection can shorten the second stage of labor，reduce postpartum bleeding and improve Neonatal score.It can provide basis for more extensive application of traditional Chinese medicine and provide new methods for clinical treatment.

[Key words]Shenfu Injection；The second stage of labor；Application effect；Apagr score；Bleeding volume

分娩是大部分女性均會(huì)經(jīng)歷的一個(gè)生理過(guò)程，但很多產(chǎn)婦在分娩過(guò)程中會(huì)發(fā)生諸多不良事件，尤其是第二產(chǎn)程時(shí)，產(chǎn)婦身心均會(huì)出現(xiàn)一系列改變，如呼吸急促、心率加快、肺內(nèi)氣體交換不足等，致使子宮收縮乏力，胎先露下降受阻，產(chǎn)程延長(zhǎng)，產(chǎn)婦體力大量消耗等，子宮收縮乏力易造成產(chǎn)后出血等不良事件的發(fā)生，對(duì)母嬰安全造成極大威脅[1]。第二產(chǎn)程是分娩過(guò)程中的重要環(huán)節(jié)，有效縮短第二產(chǎn)程時(shí)間是保障母嬰安全、緩解產(chǎn)婦疼痛、改善母嬰結(jié)局的關(guān)鍵[2]。在實(shí)際的婦產(chǎn)科臨床中，如何緩解產(chǎn)婦緊張感與疼痛感、提高自然分娩率、縮短產(chǎn)程、減少產(chǎn)后不良事件發(fā)生是目前臨床急需解決的問(wèn)題[3-4]。本研究旨在探討參附注射液在第二產(chǎn)程中的應(yīng)用效果，現(xiàn)報(bào)道如下。

1資料與方法

1.1 一般資料

選擇2017年1～5月在德興市中醫(yī)院住院分娩的80例初產(chǎn)婦作為研究對(duì)象，本研究經(jīng)我院醫(yī)學(xué)倫理委員會(huì)批準(zhǔn)。根據(jù)隨機(jī)數(shù)字表法將患者分為觀察組、對(duì)照組，每組40例。觀察組年齡21～33歲，平均（26.33±2.51）歲；孕齡37～41周，平均（39.12±0.78）周；體重50～78 kg，平均（62.47±5.61）kg。對(duì)照組年齡22～32歲，平均（26.68±2.74）歲；孕齡36～41周，平均（38.87±0.93）周；體重51～78 kg，平均（63.05±5.89）kg。兩組一般資料比較，差異無(wú)統(tǒng)計(jì)學(xué)意義（P>0.05），具有可比性。endprint